↓ Skip to main content

Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial

Overview of attention for article published in Journal of the American College of Cardiology (JACC), June 2019
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
18 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial
Published in
Journal of the American College of Cardiology (JACC), June 2019
DOI 10.1016/j.jacc.2019.03.513
Pubmed ID
Authors

David M. Charytan, Marc S. Sabatine, Terje R. Pedersen, KyungAh Im, Jeong-Gun Park, Armando Lira Pineda, Scott M. Wasserman, Prakash Deedwania, Anders G. Olsson, Peter S. Sever, Anthony C. Keech, Robert P. Giugliano

Twitter Demographics

The data shown below were collected from the profiles of 38 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 18 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 18 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 28%
Other 3 17%
Professor > Associate Professor 2 11%
Student > Master 2 11%
Student > Ph. D. Student 1 6%
Other 5 28%
Readers by discipline Count As %
Medicine and Dentistry 10 56%
Unspecified 3 17%
Computer Science 1 6%
Nursing and Health Professions 1 6%
Agricultural and Biological Sciences 1 6%
Other 2 11%

Attention Score in Context

This research output has an Altmetric Attention Score of 46. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 July 2019.
All research outputs
#367,635
of 13,396,402 outputs
Outputs from Journal of the American College of Cardiology (JACC)
#1,115
of 11,765 outputs
Outputs of similar age
#12,990
of 244,690 outputs
Outputs of similar age from Journal of the American College of Cardiology (JACC)
#81
of 222 outputs
Altmetric has tracked 13,396,402 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,765 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.8. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 244,690 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 222 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.